Skip to main content

Advertisement

SpringerLink
Log in

Serum α2-HS glycoprotein concentration in patients with hematological malignancies

A follow-up study

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

We observed significantly reduced serum α2-HS glycoprotein concentrations in patients with acute lymphocytic, acute nonlymphocytic, chronic granulocytic and chronic myelomonocytic leukemias, Hodgkin's and non-Hodgkin's lymphomas, myelofibrosis, and multiple myeloma, but not in patients with chronic lymphocytic leukemia and polycythemia vera, as compared with healthy controls. We followed the serum level of the protein for 18 months. Patients with infectious complications, those receiving cytostatic treatment, and those in the preterminal period had further reduced serum α2-HS glycoprotein levels. The reduction of serum α2-HS glycoprotein concentration was primarily due to decreased production caused by infiltration of the liver, a hepatotoxic effect of cytostatic treatment, and, to a lesser degree, to increased consumption. We found statistically significant negative correlations between serum α2-HS glycoprotein concentration and erythrocyte sedimentation rate, serum aspartate aminotransferase and alkaline phosphatase activities, and IgG and IgM concentrations. The determination of the α2-HS glycoprotein concentration is useful for the assessment and follow-up of the clinical status and therapy of patients with hematological malignancies and also has prognostic significance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Asthon BA, Smith R (1980) Plasma α2HS-glycoprotein concentration in Paget's disease of bone: its possible significance. Clin Sci 58: 435–438

    PubMed  Google Scholar 

  2. Asthon BA, Hohling HJ, Triffitt JT (1976) Plasma proteins present in human cortical bone: enrichment of the α2HS-glycoprotein. Calcif Tissue Res 22: 27–33

    PubMed  Google Scholar 

  3. Baskies AM, Chretien PB, Weiss JF, Makuch RW, Beveridge RA, Catalona ABWJ, Spiegel HE (1980) Serum glycoproteins in cancer patients: first report of correlations with in vitro and in vivo parameters of cellular immunity. Cancer 45: 3050–3060

    PubMed  Google Scholar 

  4. Bradley WP, Blasco AP, Weiss JF, Alexander JC jr, Silverman NA, Chretien PB (1977) Correlations among serum proteinbound carbohydrates, serum glycoproteins, lymphocyte reactivity, and tumor burden in cancer patients. Cancer 40: 2264–2272

    PubMed  Google Scholar 

  5. Colclasure GC, Lloyd WS, Lamkin M, Gonnermann W, Troxler RF, Offner GD, Burgi W, Schmid K, Nimberg RB (1988) Human serum α2HS glycoprotein modulates in vitro bone resorption. J Clin Endocrinol Metab 66: 187–192

    PubMed  Google Scholar 

  6. Crawford JC (1984) α2-HS glycoprotein in the hypercalcemia of multiple myeloma. Br J Cancer 49: 813–815

    PubMed  Google Scholar 

  7. Daveau M, Davrinche C, Julen N, Hiron M, Arnaud P, Lebreton JP (1988) The synthesis of human α2-HS glycoprotein is down-regulated by cytokines in hepatoma HepG2 cells. FEBS Lett 241: 191–194

    PubMed  Google Scholar 

  8. Dickson IR, Poole AR, Veis A (1975) Localisation of plasma α2HS-glycoprotein in mineralising human bone. Nature 256: 430–432

    PubMed  Google Scholar 

  9. Jakab L, Jakab LA, Kalabay L, Pozsonyi T, Cseh K (1991) The effect of the α2HS-glycoprotein on the mitogen-induced lymphocyte blastic transformation and the IL-2 production. Acta Physiol Acad Sci Hung 77:25–31

    Google Scholar 

  10. Jezequel M, Seta NS, Corbic MM, Feger JM, Durand GM (1988) Modifications of concanavalin A patterns of α1-acid glycoprotein and α2HS-glycoprotein in alcoholic liver disease. Clin Chim Acta 176: 49–58

    PubMed  Google Scholar 

  11. Kalabay L, Cseh K, Pozsonyi T, Benedek Sz, Fekete S, Jakab LA, Jakab L (1990) Serum α2HS-glycoprotein concentration in patients with acute and chronic leukemias. Blut 61: 175

    Google Scholar 

  12. Kalabay L, Jakab L, Cseh K, Pozsonyi T, Jakab LA (1990) Correlation between serum α2HS-glycoprotein concentration and conventional laboratory parameters in systemic lupus erythematosus. Acta Medica Hung 47: 53–64

    Google Scholar 

  13. Kishore BK, Gejyo F, Arakawa M (1983) α2HS-glycoprotein in the serum and urine of patients with renal diseases. Postgrad Med J 59: 304–307

    PubMed  Google Scholar 

  14. Laurell CB (1966) Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15: 45–52

    PubMed  Google Scholar 

  15. Lebreton JP, Joisel F, Raoult JP, Lannuzel B, Rogez JP, Humbert G (1979) Serum concentration of human α2HS-glycoprotein during the inflammatory process. J Clin Invest 64: 1118–1129

    PubMed  Google Scholar 

  16. Leon SA, Shapiro B, Skalroff DM, Yaros MJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37: 646–650

    PubMed  Google Scholar 

  17. Lewis JG, Andre CM (1978) A serum DNA-binding protein absent in malignant disease. FEBS Lett 92: 211–213

    PubMed  Google Scholar 

  18. Lewis JG, Andre CM (1991) Enhancement of human monocyte phagocytic function by α2HS-glycoprotein. Immunology 42: 481–487

    Google Scholar 

  19. Lewis JG, Andre CM (1984) The effect of α2HS-glycoprotein on lymphocyte reactivity to phytohemagglutinin. Immunol Commun 13: 35–47

    PubMed  Google Scholar 

  20. Lewis JG, Crosier PS, Andre CM (1982) α2HS-glycoprotein binds to lymphocytes transformed by Epstein-Barr virus. FEBS Lett 138: 37–39

    PubMed  Google Scholar 

  21. Lipson SD, Chretien PB, Makuch RW, Kenady DE, Cohen MH (1979) Thymosin immunotherapy in patients with small cell carcinoma of the lung: Correlation of in vitro studies with clinical course. Cancer 43: 863–870

    PubMed  Google Scholar 

  22. Malone JD, Richards M (1987) α2HS-glycoprotein is chemotactic for mononuclear phagocytes. J Cell Physiol 132: 118–125

    PubMed  Google Scholar 

  23. Malone JD, Teitelbaum SL, Griffin GL, Senior RM, Kahn AJ (1982) Recruitment of osteoclast precursors by purified bone matrix constituents. J Cell Biol 92: 227–230

    PubMed  Google Scholar 

  24. Mancini G, Carbonara AO, Heremans JF (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2: 235–254

    PubMed  Google Scholar 

  25. Oss van CJ, Gilman CF, Bronson PM, Border JR (1974) Opsonic properties of human serum α2HS-glycoprotein. Immunol Commun 3: 329–335

    PubMed  Google Scholar 

  26. Oss van CJ, Bronson PM, Border JR (1975) Changes in the serum α-glycoprotein distribution in trauma patients. J Trauma 15: 451–455

    PubMed  Google Scholar 

  27. Pavesi F, Merlini G, Epis R, Zorzoli I, Moratti R, Gorini M, Ascari E (1982) α2HS-glycoprotein in multiple myeloma. Haematologica (Pavia) 67: 845–852

    Google Scholar 

  28. Putnam WF (1960) The plasma proteins. Academic, New York

    Google Scholar 

  29. Richterich R, Colombo JP (1978) Klinische Chemie. Theorie, Praxis, Interpretation. Karger, Basel

    Google Scholar 

  30. Schelp FP, Thanangkul O, Supawan V, Pangpaew P (1980) α2HS-glycoprotein serum levels in protein-energy malnutrition. Br J Nutr 43: 381–385

    PubMed  Google Scholar 

  31. Triffitt JT, Gebauer U, Asthon BA, Owen ME, Reynolds JJ (1976) Origin of plasma α2HS-glycoprotein and its accumulation in bone. Nature 262: 226–227

    PubMed  Google Scholar 

  32. Wiedermann D, Wiedermann B, Cidl V, Koduskova V (1978) Individual serum proteins and acute-phase reactants in monoclonal immunoglobulinopathies. Neoplasma 25: 189–196

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 3rd Department of Medicine, Semmelweis University of Medicine, Eotvos ut 12, H-1121, Budapest, Hungary

    L. Kalabay, K. Cseh, S. Benedek, S. Fekete, T. Masszi, K. Herjeczki, T. Pozsonyi, L. Jakab & L. Jakab

Authors
  1. L. Kalabay
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Cseh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Benedek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Fekete
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Masszi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Herjeczki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. Pozsonyi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. L. Jakab
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. L. Jakab
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported by the Hungarian Academy of Sciences OTKA No. 161

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kalabay, L., Cseh, K., Benedek, S. et al. Serum α2-HS glycoprotein concentration in patients with hematological malignancies. Ann Hematol 63, 264–269 (1991). https://doi.org/10.1007/BF01698376

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01698376

Key words

Search

Navigation